HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Our HTL Biotechnology team had a great time welcoming visitors, discussing our innovations and product portfolio, and connecting with industry partners from Asia !
Thanks to everyone who stopped by our booth to connect with our experts, explore our cutting-edge pharmaceutical-grade biopolymers, and discuss the future of innovation.
๐ ๐๐๐ฅ ๐ญ๐ก๐ ๐๐ข๐๐๐๐ซ๐๐ง๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐๐ ๐๐ง๐ฌ๐ข๐๐ !
HTL Biotechnology is recognized for the second consecutive year among Franceโs most dynamic and innovative mid-sized companies.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, โShaping the Future of Aesthetic Medicine with Premium Biopolymers,โ a key initiative to strengthen our presence in Asia and promote the โFeel the Difference with HTL Insideโ positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.